These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25830706)

  • 21. Inhibitory effects of ethanol on the growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-I axis in the rat.
    Soszynski PA; Frohman LA
    Endocrinology; 1992 Dec; 131(6):2603-8. PubMed ID: 1359962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the Isolated and Combined Ablation of Growth Hormone and IGF-1 Receptors in Somatostatin Neurons.
    Chaves FM; Wasinski F; Tavares MR; Mansano NS; Frazao R; Gusmao DO; Quaresma PGF; Pedroso JAB; Elias CF; List EO; Kopchick JJ; Szawka RE; Donato J
    Endocrinology; 2022 May; 163(5):. PubMed ID: 35395079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM; Gahete MD; Valentine RJ; Kineman RD
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothalamic/pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid.
    Kamegai J; Unterman TG; Frohman LA; Kineman RD
    Endocrinology; 1998 Aug; 139(8):3554-60. PubMed ID: 9681507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes.
    Kim E; Sohn S; Lee M; Jung J; Kineman RD; Park S
    J Endocrinol; 2006 Feb; 188(2):263-70. PubMed ID: 16461552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.
    Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
    Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats.
    Sato M; Frohman LA
    Endocrinology; 1993 Aug; 133(2):793-9. PubMed ID: 8102097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orexins (hypocretins) actions on the GHRH/somatostatin-GH axis.
    López M; Nogueiras R; Tena-Sempere M; Diéguez C
    Acta Physiol (Oxf); 2010 Mar; 198(3):325-34. PubMed ID: 19769635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autofeedback suppression of growth hormone (GH) secretion in transgenic mice expressing a human GH reporter targeted by tyrosine hydroxylase 5'-flanking sequences to the hypothalamus.
    Szabo M; Butz MR; Banerjee SA; Chikaraishi DM; Frohman LA
    Endocrinology; 1995 Sep; 136(9):4044-8. PubMed ID: 7649113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothalamic distribution of somatostatin mRNA expressing neurones relative to pubertal and adult changes in pulsatile growth hormone secretion in mice.
    Tan HY; Huang L; Simmons D; Veldhuis JD; Steyn FJ; Chen C
    J Neuroendocrinol; 2013 Oct; 25(10):910-9. PubMed ID: 23855876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mice with an RGS-insensitive Gα
    Omouessi ST; Leipprandt JR; Akoume MY; Charbeneau R; Wade S; Neubig RR
    Mol Cell Endocrinol; 2021 Feb; 521():111098. PubMed ID: 33278490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans.
    Gottero C; Prodam F; Destefanis S; Benso A; Gauna C; Me E; Filtri L; Riganti F; Van Der Lely AJ; Ghigo E; Broglio F
    Growth Horm IGF Res; 2004 Oct; 14(5):382-7. PubMed ID: 15336231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Truncated somatostatin receptors as new players in somatostatin-cortistatin pathophysiology.
    Córdoba-Chacón J; Gahete MD; Durán-Prado M; Luque RM; Castaño JP
    Ann N Y Acad Sci; 2011 Mar; 1220():6-15. PubMed ID: 21388399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyrotropin-Releasing Hormone (TRH) and Somatostatin (SST), but not Growth Hormone-Releasing Hormone (GHRH) nor Ghrelin (GHRL), Regulate Expression and Release of Immune Growth Hormone (GH) from Chicken Bursal B-Lymphocyte Cultures.
    Pech-Pool S; Berumen LC; Martínez-Moreno CG; García-Alcocer G; Carranza M; Luna M; Arámburo C
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial reversibility of growth hormone (GH) deficiency in the GH-releasing hormone (GHRH) knockout mouse by postnatal treatment with a GHRH analog.
    Alba M; Schally AV; Salvatori R
    Endocrinology; 2005 Mar; 146(3):1506-13. PubMed ID: 15564325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A model for tissue-specific inducible insulin-like growth factor-I (IGF-I) inactivation to determine the physiological role of liver-derived IGF-I.
    Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
    Endocrine; 2002 Dec; 19(3):249-56. PubMed ID: 12624424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
    Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
    J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.